Search results for "Reduct"

showing 10 items of 2879 documents

The mandibular angle in osteoporotic men

2010

Objectives: Osteoporosis induces the reduction of bone mass and screening for low bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) has been the current gold standard test to determine osteoporosis. Panoramic radiography is widely used in dentistry for routine examination of jaws. The objective of this study was to determine the relationship between the mandibular angle (MA) values and the vertebral bone mineral density (v-BMD) in 20 osteoporotic men. Study design: In panoramic radiograms of osteoporotic men, the means were calculated for the mandibular angle values measured in the right and left mandible. v-BMD values were also calculated by manual analysis of DXA scans.…

AdultMaleDental practiceRadiographymedicine.medical_treatmentOsteoporosisDentistryMandibleMandibular anglestomatognathic systemBone DensityRadiography PanoramicmedicineHumansGeneral DentistryReduction (orthopedic surgery)Vertebral boneAgedBone mineralbusiness.industryMandibleMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASOsteoporosisSurgerybusiness
researchProduct

Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism

2010

ObjectivesThe purpose of this study was to determine whether single-dose rosuvastatin (40 mg) protects against ischemia and reperfusion (IR)–induced endothelial dysfunction in humans and whether this effect is cyclooxygenase (COX)-2 dependent.BackgroundAnimal studies have demonstrated that rosuvastatin can limit damage and improve recovery after IR.MethodsIn a double-blind, parallel design, 20 volunteers were randomized to a single dose of oral rosuvastatin (40 mg) or placebo. Twenty-four hours later, endothelium-dependent, flow-mediated dilation (FMD) of the radial artery was measured before and after IR (15 min of upper arm ischemia followed by 15 min of reperfusion). In a separate protoc…

AdultMaleEndotheliumendotheliumAdolescentPremedicationIschemiaMyocardial Reperfusion InjuryPharmacologyPlaceboYoung AdultDouble-Blind Methodmedicineischemia reperfusionHumansRosuvastatinEndothelial dysfunctionRosuvastatin CalciumSulfonamidesCyclooxygenase 2 Inhibitorsbusiness.industryModels Cardiovascularnutritional and metabolic diseases3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitormedicine.diseaseFluorobenzenesVasodilationRosuvastatin Calciummedicine.anatomical_structurePyrimidinesCelecoxibCyclooxygenase 2AnesthesiaIschemic Preconditioning MyocardialRadial ArteryCelecoxibIschemic preconditioningPyrazolesFemaleEndothelium VascularHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCardiology and Cardiovascular Medicinerosuvastatinmedicine.drugJournal of the American College of Cardiology
researchProduct

Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

2020

The EUGEI project was supported by the European Community’s Seventh Framework Program under grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O’Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/ L010305/1). Dr Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation. Drs Guloksuz and van Os are supported by the Ophelia research project, ZonMw grant number: 636340001. Dr Arango was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024); CIBERSAM; Madrid Regional Government (B2017/BMD-3740, AGES-CM-2); Fundación Familia Alonso and Fundac…

AdultMaleExposomePsychosisMultifactorial InheritanceEpidemiologyBIRTHSchizotypystructured interviewGENE-ENVIRONMENTPopulationschizotypypopulationEnvironment03 medical and health sciences0302 clinical medicineMedicineHumansSpectrum disorderGenetic Predisposition to DiseasegeneticspsychosiseducationMETAANALYSISvalidationRISKeducation.field_of_studychildhood traumareliabilitybusiness.industryPublic Health Environmental and Occupational HealthAbsolute risk reductionassociationRegression analysisGenomicsmedicine.disease3. Good health030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleGene-Environment InteractionSchizophrenic PsychologyOriginal Articlebusiness030217 neurology & neurosurgeryClinical psychologyEpidemiology and Psychiatric Sciences
researchProduct

Cardiovascular prevention and at-risk behaviours in a large population of amateur rugby players.

2019

Background and aim We aimed to investigate cardiovascular risk factors and health behaviours prospectively in a large population of French amateur rugby players. Methods An anonymous questionnaire was displayed to rugby players aged over 12 years enrolled in the 2014–2015 French amateur rugby championship from the Burgundy region ( n = 5140). Questions addressed awareness on: (a) cardiovascular prevention; (b) tobacco, alcohol and highly caffeinated beverages consumption; and (c) adherence to prevention guidelines (ECG checks, training in basic life support, avoidance of sports practice during fever/infectious episodes). Results Among the 640 participants who completed the questionnaires, m…

AdultMaleHealth Knowledge Attitudes PracticeAdolescentAlcohol DrinkingFeverEpidemiologyCardiovascular risk factorsHealth BehaviorLarge populationFootball030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesElectrocardiographyYoung Adult0302 clinical medicineCardiovascular preventionRisk FactorsEnvironmental healthCaffeineMedicineHumansProspective StudiesChildLife StyleAgedbusiness.industrySmoking030229 sport sciencesMiddle AgedProtective FactorsAthletesCardiovascular DiseasesFemaleFranceCardiology and Cardiovascular MedicinebusinessAmateurRisk Reduction BehaviorEuropean journal of preventive cardiology
researchProduct

Editor's Note: Relates to: ‘Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to p…

2020

Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD). Methods and results Of the theoretical estimated prevalence of 1/500 for heterozygous FH, <1% are diagnosed in most countries. Recently, direct screening in a Northern European general population diagnosed approximately 1/200 with heterozygous FH. All reported studies document failure to achieve recommended LDL cholesterol targets in a large proportion of individuals with FH, and up to 13-fold increased risk of CHD. Based on prevalen…

AdultMaleHeterozygoteConsensusCost-Benefit AnalysisCoronary DiseaseRisk AssessmentHyperlipoproteinemia Type IIHumansAcademicSubjects/MED00200ChildAnticholesteremic AgentsLow-density lipoproteinHomozygoteCholesterol LDLMiddle AgedCardiovascular diseaseAtherosclerosisCorrigendaPedigreeCoronary heart diseaseCholesterolEarly DiagnosisTreatment OutcomeCurrent OpinionChild PreschoolMutationFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsDelivery of Health CareForecastingEuropean Heart Journal
researchProduct

In vivoprooxidant state in Werner syndrome (WS): Results from three WS patients and two WS heterozygotes

2005

The hypothesis was tested that Werner syndrome (WS) phenotype might be associated with an in vivo prooxidant state. A set of redox-related endpoints were measured in three WS patients, two of their parents, and 99 controls within a study of some cancer-prone and/or ageing-related genetic disorders. The following analytes were measured: (a) leukocyte 8-hydroxy-2'-deoxyguanosine; (b) glutathione from whole blood, and (c) plasma levels of glyoxal, methylglyoxal, 8-isoprostane, and some plasma antioxidants (uric acid, ascorbic acid, alpha- and gamma-tocopherol). Leukocyte 8-hydroxy-2'-deoxyguanosine levels showed a significant increase in the 3 WS patients vs. 85 controls (p<10(-7)). The disulf…

AdultMaleHeterozygotemedicine.medical_specialtyDinoprostmedicine.disease_causeBiochemistryAntioxidantschemistry.chemical_compoundIn vivoInternal medicineLeukocytesmedicineHumansDeoxyguanosineChromatography High Pressure LiquidMethylglyoxalDeoxyguanosine8-Hydroxy-2'-deoxyguanosineGlyoxalGeneral MedicineGlutathioneMiddle AgedPyruvaldehydeAscorbic acidGlutathioneEndocrinologychemistryBiochemistry8-Hydroxy-2'-DeoxyguanosineUric acidFemaleWerner SyndromeOxidation-ReductionOxidative stressFree Radical Research
researchProduct

Effects of gender on resting leg blood flow: implications for measurement of regional substrate oxidation.

1998

Jensen, Michael D., Tu T. Nguyen, A. Hernández Mijares, C. Michael Johnson, and Michael J. Murray. Effects of gender on resting leg blood flow: implications for measurement of regional substrate oxidation. J. Appl. Physiol. 84(1): 141–145, 1998.—These studies were designed to examine whether the respiratory quotient (RQ) of leg tissue (primarily skeletal muscle) would increase to a greater degree in women than in men during meal ingestion. We found that mean leg and systemic RQ values were similar in men under both basal and fed conditions, whereas the agreement was poor in women. In women, leg RQ values tended to be greater than the systemic RQ, whereas splanchnic RQ values tended to be l…

AdultMaleLegSex CharacteristicsPhysiologyChemistryHemodynamicsCalorimetry IndirectBlood flowAnatomyCarbon DioxideSubstrate (marine biology)Lower limbOxygenRegional Blood FlowPhysiology (medical)Body CompositionHumansFemaleSplanchnic CirculationBlood carbon dioxideOxidation-ReductionJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct

Predictors of weight loss after an intensive lifestyle intervention program in obese patients: a 1-year prospective cohort study.

2013

Published Version of an article in the journal: Health and Quality of Life Outcomes. Also available from the publisher at: http://dx.doi.org/10.1186/1477-7525-11-165 Open access Background Studies of lifestyle intervention programs in morbid obesity report large variations in weight loss outcomes. This is reported not only between but also within standardized programs. Such reports point to participants’ characteristics as possible predictors of this outcome. The aim of this prospective cohort study was to identify predictors of weight loss after a 1-year partly residential intensive lifestyle intervention program (ILI). Methods Morbidly obese patients (n=199), all Caucasian, 71% women, mea…

AdultMaleLifestyle interventionmedicine.medical_specialtyWeight lossType 2 diabetesCohort StudiesMorbid obesityQuality of lifeWeight lossInternal medicineOutcome Assessment Health CaremedicineHumansHealth related quality of lifeProspective StudiesProspective cohort studyLife Stylebusiness.industryNorwayPredictorsResearchPublic Health Environmental and Occupational HealthGeneral MedicineVDP::Medical disciplines: 700::Health sciences: 800AnthropometryMiddle Agedmedicine.diseaseObesityCombined Modality TherapyObesity MorbidPhysical therapyLinear ModelsFemalemedicine.symptombusinessBody mass indexRisk Reduction BehaviorCohort studyForecastingHealth and quality of life outcomes
researchProduct

Oxyphytosterols are present in plasma of healthy human subjects

2004

The oxidised derivatives of phytosterols (oxyphytosterols) were identified in plasma samples from thirteen healthy human volunteers, using MS. All the samples contained noticeable quantities of (24R)-5b,6b-epoxy-24-ethylcholestan-3b-ol (b-epoxysitostanol) and (24R)-ethylcholestan-3b,5a,6b-triol (sitostanetriol) and also trace levels of (24R)-5a,6a-epoxy-24-ethylcholestan-3b-ol (a-epoxysitostanol), (24R)-methylcholestan-3b,5a,6b-triol (campestanetriol) and (24R)-ethylch olest-5-en-3b-ol-7-one(7-ketositosterol). The amounts of these oxyphytosterols in plasma varied from 4·8 to 57·2 ng/ml. There are two possibilities concerning the origin of these compounds. First, they could come from the sma…

AdultMaleMedicine (miscellaneous)Mass spectrometryGas Chromatography-Mass Spectrometry03 medical and health sciences0404 agricultural biotechnologyBlood plasmaHumansComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesNutrition and DieteticsChromatographyPlasma samplesChemistryHealthy subjectsPhytosterols04 agricultural and veterinary sciencesMiddle AgedSitosterols040401 food science3. Good health[SDV.AEN] Life Sciences [q-bio]/Food and NutritionHuman plasmaFemaleOxidation-Reduction[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBritish Journal of Nutrition
researchProduct

Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application

1994

Pharmacokinetics and bioavailability of benperidol were determined in 13 schizophrenic patients after acute administration of 6 mg benperidol as an intravenous (i.v.) bolus injection, orally as liquid, and orally as tablets using a partially randomized cross-over design. Drug plasma levels were determined by high performance liquid chromatography with electrochemical detection and subjected to model independent pharmacokinetic analyses. After i.v. dosing the geometric means (mean-g) were 3.2 min for the distribution half-life, 5.80 h for the elimination half-life (t1/2 beta), 4.21 l/kg for the distribution volume, 7.50 h for the mean residence time (MRT), and 0.50 l/(h*kg) for the clearance…

AdultMaleMetaboliteAdministration OralBiological AvailabilityPharmacologyHigh-performance liquid chromatographyBenperidolchemistry.chemical_compoundPharmacokineticsOral administrationmedicineHumansDistribution (pharmacology)PharmacologyCross-Over StudiesChemistryBenperidolMiddle AgedBioavailabilityInjections IntravenousSchizophreniaFemaleGeometric meanOxidation-ReductionHalf-Lifemedicine.drugPsychopharmacology
researchProduct